Skip to main content

ING GROEP NV

Position in GILD — Gilead Sciences, Inc.

CIK 1039765 AMSTERDAM, P7

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,705,514
-$21,698,530 QoQ
Shares Held
45,160
-77.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#550
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ING GROEP NV holds $464,230,493 across 8 Drug Manufacturers - General names. GILD ranks #8 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 GILD
Gilead Sciences, Inc.
This page
45,160 $5,705,514

All Filings in GILD

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,705,514 45,160
2026-03-31 $27,404,044 196,628
2025-12-31 $44,720,809 364,354
2025-09-30 $20,725,032 186,712
2025-06-30 $31,882,664 287,568
2025-03-31 $35,298,887 315,028
2024-12-31 $23,959,207 259,383
2024-09-30 $32,922,710 392,685
2024-06-30 $19,409,563 282,897
2024-03-31 $22,116,226 301,928
2023-12-31 $75,498,727 931,968
2023-09-30 $35,530,627 474,121
2023-06-30 $59,722,467 774,912
2023-03-31 $19,972,372 240,718
2022-12-31 $28,796,837 335,432
2022-09-30 $17,812,247 288,738
2022-06-30 $19,559,589 316,447
2022-03-31 $16,624,360 279,636
2021-12-31 $16,318,879 224,747
2021-09-30 $9,322,111 133,459
2021-06-30 $9,000,759 130,711
2021-03-31 $5,738,368 88,788
2020-12-31 $4,960,547 85,145
2020-09-30 $1,879,712 29,747
2020-06-30 $1,020,147 13,259
2020-03-31 $10,782,784 144,232